Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 250 results for "lupin ltd"

Clarification sought from Lupin Ltd (SCRIPCODE: 500257)

Health & Lifestyle ACCORD FINTECH BSE Online News India, May 27 -- The Exchange has sought clarification from Lupin Ltd on May 27, 2016 with reference to news reported in CNBC TV 18 on May 27, 2016- "Mandideep unit Gets Establishment Inspection ... HT Syndication, 1 day ago
Lupin's FY16 results on May 19, 2016 Money Control, 3 weeks ago

6 images for lupin ltd

Livemint.com, 3 weeks ago
Forbes India, 1 week ago
Livemint.com, 3 weeks ago
India Infoline, 1 week ago
Firstpost.com, 1 week ago
Siasat Daily, 4 weeks ago

Lupin shines on receiving EIR for Mandideep and Aurangabad units

SENSEX 26565.29 198.61 0.75% NIFTY 8131.20 61.55 0.76% Industry: Medical/Healthcare Company Lupin Ltd Lupin is currently trading at Rs. 1503.30, up by 33.20 points or 2.26% from its previous closing of Rs. 1470.10 on the BSE.
 Finalaya.com1 day ago Lupin trades high on the bourses  Finalaya.com2 months ago
India Infoline

Lupin FY16 PAT lower at Rs. 2270.69 crores

Posted On: 2016-05-25 23:55:21 Lupin Ltd has announced the financial results for the quarter & year ended March 31, 2016. The Company has posted a net profit of Rs. 9249.30 million for the quarter ended March 31, 2016 as compared to Rs. 4077.00 ...
 Equity Bulls2 days ago Lupin Ltd 19 May 2016  India Infoline1 week ago Lupin Q4 profit beats estimates as U.S. sales jump  Reuters1 week ago Lupin Q4 net up 48%; beats estimates  Business Line1 week ago
[x]  
Livemint.com

Lupin gets USFDA nod for anti-cholesterol drug

Chennai, Aug 20 (IANS) Pharmaceutical major Lupin Ltd on Thursday said it has got the USFDA approval for anti-cholesterol tablet though a sector analyst said the drug may not contribute to the company's financials majorly. Lupin, in a statement, ...
 Yahoo! India1 week ago Glenmark gets FDA final approval to sell anti-epileptic drug in US  Livemint.com1 week ago
India Infoline

Top 15 stocks in focus today: Lupin, Tata Comm, Parag Milk Foods

Lupin: Lupin Ltd, one of the leading pharmaceutical companies in India, will announce its Q4 number today. IIFL estimates the company's net profit to propel to Rs.704 crore, at a rate of 28.7% yoy and 32.8% qoq. Reliance Industries: Reliance ...
 India Infoline1 week ago Top 14 stocks in focus today: Maruti Suzuki, Lupin, IOC  India Infoline1 month ago

Lupin Ltd Board recommends Dividend of Rs. 7.50

Posted On: 2016-05-25 23:54:11 The Board of Directors of Lupin Ltd at its meeting held on May 19, 2016, recommended dividend @ 375% i.e. Rs. 7.50 per equity share of the face value of Rs. 2/- each for the year ended March 31, 2016, subject to ...
 Equity Bulls2 days ago Lupin recommends dividend  Money Control1 week ago

Lupin shares fall most since November 2008 on USFDA concerns about Goa plant [Mint, New Delhi]

May 20--MUMBAI -- Shares of Lupin Ltd fell 9.10% on Friday, the most since 11 November 2008, despite the better-than-expected earnings as investors are awaiting more clarity on the observation made by the US drug regulator, US Food and Drug ...
 Bloomberg1 week ago

Lupin dips on USFDA concerns about Goa plant

Related to : Lupin Ltd Lupin Ltd BSE 20 May 16 | 10:02 AM 1539.15 -116.65 (-7.04%) NSE 20 May 16 | 09:24 AM 1568.55 -86.9 (-5.25%) Lupin has dipped almost 8% to Rs 1,525 on the BSE in early morning trade on the BSE, as analyst ...
 Smart Investor1 week ago
India Infoline

Lupin receives establishment Inspection Report for Mandideep and Aurangabad units

Pharma Major Lupin announced that it has received Establishment Inspection Reports (EIR) for its Mandideep and Aurangabad facilities wherein the US FDA has concluded that the inspections stand closed. The US FDA had conducted audits at Lupin's ...
 India Infoline1 day ago

Glenmark launches digital inhaler for asthma, obstructive pulmonary disease

Glenmark planning to launch more drugs to support Digihaler in coming months Hyderabad: Glenmark Pharmaceuticals Ltd on Wednesday launched Digihaler, India's first digital dose inhaler for asthma and chronic obstructive pulmonary disease (COPD) ...
 Livemint.com2 days ago BRIEF: Glenmark launches digital inhaler for asthma, obstructive pulmonary disease [Mint, New Delhi]  Bloomberg2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less